Long-term changes to lung mechanics following smoke exposure are cause for concern [0.03%]
长期吸烟对肺部造成的改变值得警惕
Stephanie Holm
Stephanie Holm
Development and validation of a model for diagnosis of obstructive sleep apnoea in primary care [0.03%]
基层医疗阻塞性睡眠呼吸暂停综合征诊断模型的建立和验证
Julia L Chapman,Camilla M Hoyos,Roo Killick et al.
Julia L Chapman et al.
Background and objective: Use of in-laboratory polysomnography (PSG) to diagnose obstructive sleep apnoea (OSA) is cost and resource intensive. Questionnaires, physical measurements and home monitors have been studied as ...
Associations between respiratory and vascular function in early childhood [0.03%]
学龄前儿童呼吸功能与血管功能的相关性研究
Emily J Hemstock,Jingyi Shao,Bing Zhao et al.
Emily J Hemstock et al.
Background and objective: The link between respiratory and vascular health is well documented in adult populations. Impaired lung function is consistently associated with thicker arteries and higher incidence of cardiovas...
Semra Bilaçeroğlu
Semra Bilaçeroğlu
Yet H Khor
Yet H Khor
Pulmonary vascular involvement in COVID-19 pneumonitis: Is this the first and final insult? [0.03%]
COVID-19肺炎的肺血管受累：这是第一次也是最后一次损伤吗？
Laura Claire Price,Carole Ridge,Athol U Wells
Laura Claire Price
See related article Keywords: COVID-19 pneumonitis; dual-energy perfusion CT scanning; endothelial injury; ...
Patrick Berger,Isabelle Dupin
Patrick Berger
Defining successful non-invasive ventilation initiation: Data from a real-life cohort [0.03%]
基于真实世界队列的无创通气成功启动定义的数据收集
Grégoire Jolly,Léa Razakamanantsoa,Emeline Fresnel et al.
Grégoire Jolly et al.
Background and objective: When home non-invasive ventilation (NIV) is initiated, five goals need to be achieved: a daily use >4 h/day, an improvement in gas exchange, health-related quality of life (HRQL) and sleep qualit...
We can do better in COPD: Time for action to preserve body composition [0.03%]
我们可以做得更好：及时采取措施保护慢阻肺患者的体质组成
Lisa G Wood
Lisa G Wood
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort [0.03%]
特发性肺纤维化患者接受尼达尼布或吡非尼酮治疗的预后：多中心真实世界队列研究
Michael T Durheim,Elisabeth Bendstrup,Lisa Carlson et al.
Michael T Durheim et al.
Background and objective: Antifibrotic therapy with nintedanib or pirfenidone slows disease progression and reduces mortality in patients with idiopathic pulmonary fibrosis (IPF). However, patients with advanced IPF, as d...
Multicenter Study
Respirology (Carlton, Vic.). 2021 Oct;26(10):982-988. DOI:10.1111/resp.14116 2021